The latest update is out from HeraMED Ltd. ( (AU:HMD) ).
HeraMED Ltd. has released its corporate governance statement for the financial year ending December 31, 2024, which has been approved by the board as of February 28, 2025. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, indicating that the company has followed these guidelines throughout the reporting period. This release underscores HeraMED’s commitment to transparency and accountability, potentially strengthening its position in the market and reassuring stakeholders of its governance practices.
More about HeraMED Ltd.
HeraMED Ltd. operates in the healthcare technology industry, focusing on developing innovative medical devices and solutions aimed at enhancing patient care and monitoring.
YTD Price Performance: 10.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €8.92M
For a thorough assessment of HMD stock, go to TipRanks’ Stock Analysis page.